高清福利片

Save Sight Institute

false

Clinical trials

We offer patients emerging treatments for macular diseases.

Browse a list of current, upcoming and previous clinical trials conducted through the Clinical Research Unit.

Enrolling and upcoming clinical trials

Trial Condition Details
MALBEC Wet AMD

Ethics approval SVHM HREC 050/26

Biojiva

(Opening Soon)

Geographic Atrophy (GA)

Ethics appoval Bellberry 2025/ETH01765

ADARx

(Opening Soon)

Geographic Atrophy (GA)

Ethics approval SVHM 161/25
Star-MOG  Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease

Ethics approval RPAH 2024/ETH02047
Encelto MacTel Type II

Ethics approval SVHM 218/25
Hyperion (opening soon) Leber Congential Amaurosis (LCA)

Ethics approval SVHM 104/25 & SCHN 2025/ETH01223
Therini DME  Diabetic Macular Oedema

Ethics approval Bellberry 2025/ETH00734
KLARITY Central Macular Oedema

Ethics approval  SVHM HREC 309/24
iSight-2 Dry AMD to late Dry AMD

Ethics approval Bellberry 2024/ETH02730
Vantage Non -proliferative Diabetic Retinopathy

Ethical approval SVHM HREC 250/24
BenoBio Wet AMD

Ethical approval Bellberry HREC 2024/ETH01779
RADAR Diabetic Eye Disease Ethical approval HREC/13/SAC/92
MacTel Project MacTel

Ethical approval HREC/16/POWH/215

Current clinical trials

  •  (Dry AMD) - HREC/99641/SVHM-2023-378051
  •  - HREC/70305/SVHM-2021-264245
  •  - HREC/69746/2020-001313-20
  • - HREC 2024/ETH01779
  • - HREC 2025/PID00031 
  • - HREC/230/24
  • - SVHM HREC 310/24
  • - HREC 2024/ETH02730

  •  - HREC/94784/SVHM-2023-358921
  • RADAR - HREC/13/SAC/92
  • 鈥� HREC 2024/PID00308
  • - SESLHD 2025/ETH00492
  • - 2025/ETH00734

  • - HREC 161/25
  • - HREC 2025/ETH01765

  •  鈥� HREC/102954/SVHM-2023-400792(v2)

  • 鈥� SVHM 218/25

Completed clinical trials

  •  - HREC/15/RPAH/167
  •  - HREC/13/SHA/46
  •  - HREC/15/RPAH/394
  •  - HREC/14/RPAH/287
  •  - HREC/16/POWH/543
  •  - HREC/15/RPAH/347
  •  - HREC/15/RPAH/387
  •  - HREC/53858/SVHM-2019
  •  - HREC/18/SVHM/251
  •  - HREC/49517/SVHM-2019
  •  - HREC/18/SVHM/252
  •  - HREC/70671/SVHM-2021-263810 
  •  - HREC/67626/SVHM-2020-232811
  •  - SVHM HREC 294/20
  •  - HREC/72069/SVHM-2020-244368
  •  - CALHN HREC 2021/HRE00112 
  •  - HREC/50571/SVHM-2018 
  •  - HREC/52072/SVHM-2019 
  • PULSAR (Wet AMD) and PULSAR Ext (Wet AMD) - HREC/63698/SVHM-2020-213156
  • - HREC/103832/SVHM-2023-400811
  • - HREC/77051/SVHM-2021-273676

  •  - HREC/17/POWH/178
  •  - HREC/18/MH/103
  •  - HREC/51264/SVHM-2019
  •  - HREC/67565/SVHM-2020-226369
  •  - HREC/65076/SVHM-2020-230166
  •  - HREC/65387/SVHM-2020-219227
  •  - HREC/61973/SVHM-2020
  • - HREC/97356/SVHM-2023-36744

  •  - HREC/16/RAH/250
  •  - HREC/12/RPAH/547
  • Genetic study of Diabetic Retinopathy - SESLHD HREC 08/213
  •  - HREC/14/RPAH/205
  •  - LNR/17/POWH/619
  •  - HREC/14/RPAH/204
  •  - HREC/18/SVHM/149
  •  - HREC/18/SVHM/240
  •  - HREC/67565/SVHM-2020-226369
  •  - Bellberry HREC 2020/ETH02613
  •  - HREC/63535/SVHM-2020
  •  - HREC/68388/SVHM-2020-230633
  • -  HREC/103584/SVHM-2023
  • BIOCRYST (DME) 鈥� HREC 2025/ETH00954

  •  - HREC/13/RPAH/393
  •  - SCGOPHCG HREC  RGS0000004826
  •  - HREC/17/SVHM/192

  • - Ethical approval HREC/101598/SVHM-2023

Patient feedback

"I was so happy with the whole team's service and with how kind everyone was at every visit. It felt like family and 'home'. "

鈥淚 feel very honoured to be part of clinical trials helping find new medications for future patients...the research team provides a very high level of service to the patients involved.鈥�

鈥淢y experience with the clinical trials team has been very good and I am very appreciative of the support that I received throughout my time with them.鈥�

Hear more from our patients .